Literature DB >> 15238351

Recovery of Na-glucose cotransport activity after renal ischemia is impaired in mice lacking vimentin.

Isabelle Runembert1, Sylviane Couette, Pierre Federici, Emma Colucci-Guyon, Charles Babinet, Pascale Briand, Gérard Friedlander, Fabiola Terzi.   

Abstract

Vimentin, an intermediate filament protein mainly expressed in mesenchyma-derived cells, is reexpressed in renal tubular epithelial cells under many pathological conditions, characterized by intense cell proliferation. Whether vimentin reexpression is only a marker of cell dedifferentiation or is instrumental in the maintenance of cell structure and/or function is still unknown. Here, we used vimentin knockout mice (Vim(-/-)) and an experimental model of acute renal injury (30-min bilateral renal ischemia) to explore the role of vimentin. Bilateral renal ischemia induced an initial phase of acute tubular necrosis that did not require vimentin and was similar, in terms of morphological and functional changes, in Vim(+/+) and Vim(-/-) mice. However, vimentin was essential to favor Na-glucose cotransporter 1 localization to brush-border membranes and to restore Na-glucose cotransport activity in regenerating tubular cells. We show that the effect of vimentin inactivation is specific and results in persistent glucosuria. We propose that vimentin is part of a structural network that favors carrier localization to plasma membranes to restore transport activity in injured kidneys.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15238351     DOI: 10.1152/ajprenal.00064.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  9 in total

Review 1.  Roles of vimentin in health and disease.

Authors:  Karen M Ridge; John E Eriksson; Milos Pekny; Robert D Goldman
Journal:  Genes Dev       Date:  2022-04-01       Impact factor: 12.890

2.  A mitotic transcriptional switch in polycystic kidney disease.

Authors:  Francisco Verdeguer; Stephanie Le Corre; Evelyne Fischer; Celine Callens; Serge Garbay; Antonia Doyen; Peter Igarashi; Fabiola Terzi; Marco Pontoglio
Journal:  Nat Med       Date:  2009-12-06       Impact factor: 53.440

Review 3.  Vimentin's side gig: Regulating cellular proteostasis in mammalian systems.

Authors:  Christopher S Morrow; Darcie L Moore
Journal:  Cytoskeleton (Hoboken)       Date:  2020-11-26

Review 4.  Intermediate filaments take the heat as stress proteins.

Authors:  D M Toivola; P Strnad; A Habtezion; M B Omary
Journal:  Trends Cell Biol       Date:  2010-01-04       Impact factor: 20.808

5.  Vimentin expression is required for the development of EMT-related renal fibrosis following unilateral ureteral obstruction in mice.

Authors:  Zheng Wang; Alex Divanyan; Frances L Jourd'heuil; Robert D Goldman; Karen M Ridge; David Jourd'heuil; Reynold I Lopez-Soler
Journal:  Am J Physiol Renal Physiol       Date:  2018-04-04

Review 6.  Epithelial transport during septic acute kidney injury.

Authors:  Eric D Morrell; John A Kellum; Kenneth R Hallows; Núria M Pastor-Soler
Journal:  Nephrol Dial Transplant       Date:  2013-12-29       Impact factor: 5.992

7.  Catheter-based induction of renal ischemia/reperfusion in swine: description of an experimental model.

Authors:  Pamella A Malagrino; Gabriela Venturini; Patrícia S Yogi; Rafael Dariolli; Kallyandra Padilha; Bianca Kiers; Tamiris C Gois; Joaquim M da Motta-Leal-Filho; Celso K Takimura; Adriana C C Girardi; Francisco C Carnevale; Ana C M Zeri; Denise M A C Malheiros; José E Krieger; Alexandre C Pereira
Journal:  Physiol Rep       Date:  2014-09-28

Review 8.  Vimentin on the move: new developments in cell migration.

Authors:  Rachel A Battaglia; Samed Delic; Harald Herrmann; Natasha T Snider
Journal:  F1000Res       Date:  2018-11-15

9.  Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates.

Authors:  Christine Dieterich; Angela Puey; Sylvia Lin; Sylvia Lyn; Robert Swezey; Anna Furimsky; David Fairchild; Jon C Mirsalis; Hanna H Ng
Journal:  Toxicol Sci       Date:  2008-10-16       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.